Variant report
Variant | esv3367115 |
---|---|
Chromosome Location | chr12:75684235-75687733 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:8)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:8 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr12:75684802-75685162 | HepG2 | liver: | n/a | chr12:75684985-75684996 |
2 | CEBPB | chr12:75684893-75685084 | HepG2 | liver: | n/a | chr12:75684985-75684996 |
3 | CEBPB | chr12:75684823-75685090 | A549 | lung: | n/a | chr12:75684985-75684996 |
4 | FOXA1 | chr12:75683996-75684379 | HepG2 | liver: | n/a | chr12:75684093-75684105 |
5 | GATA1 | chr12:75687653-75688681 | PBDE | blood: | n/a | n/a |
6 | GATA3 | chr12:75685564-75685658 | SH-SY5Y | brain: | n/a | n/a |
7 | STAT3 | chr12:75684384-75684410 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | STAT3 | chr12:75684948-75685002 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:75143585..75146196-chr12:75682282..75684719,2 | MCF-7 | breast: | |
2 | chr12:75675181..75678021-chr12:75682376..75684656,2 | MCF-7 | breast: | |
3 | chr12:75665105..75667577-chr12:75682796..75684340,2 | MCF-7 | breast: | |
4 | chr12:75140866..75141740-chr12:75683619..75684268,4 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000254451 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs578033589 | chr12:75684237-75684238 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs192620990 | chr12:75684246-75684247 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs147196976 | chr12:75684264-75684265 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs6582284 | chr12:75684326-75684327 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs143426208 | chr12:75684361-75684362 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs542633012 | chr12:75684377-75684378 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs559346790 | chr12:75684417-75684418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34138210 | chr12:75684428-75684429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528103851 | chr12:75684429-75684430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs376513817 | chr12:75684434-75684435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs560285857 | chr12:75684465-75684466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565015817 | chr12:75684496-75684497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185108218 | chr12:75684503-75684504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190405219 | chr12:75684541-75684542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs147137457 | chr12:75684554-75684555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541534491 | chr12:75684558-75684559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536596081 | chr12:75684559-75684560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181270218 | chr12:75684563-75684564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs566487696 | chr12:75684575-75684576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs368518754 | chr12:75684588-75684589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs538663185 | chr12:75684714-75684715 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs202183644 | chr12:75684715-75684716 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs202155768 | chr12:75684716-75684717 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs67415251 | chr12:75684717-75684718 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558753898 | chr12:75684724-75684725 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs200534312 | chr12:75684725-75684726 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs201091623 | chr12:75684726-75684727 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs372814202 | chr12:75684763-75684764 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536826549 | chr12:75684798-75684799 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs557158326 | chr12:75684813-75684814 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs573847915 | chr12:75684920-75684921 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs542904811 | chr12:75684924-75684925 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs10785183 | chr12:75684935-75684936 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs184690249 | chr12:75685000-75685001 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs7980652 | chr12:75685074-75685075 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs140447424 | chr12:75685080-75685081 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs564813576 | chr12:75685141-75685142 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs530671807 | chr12:75685191-75685192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs139001261 | chr12:75685207-75685208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574397513 | chr12:75685259-75685260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs556770226 | chr12:75685261-75685262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544476330 | chr12:75685281-75685282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561486854 | chr12:75685284-75685285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530239564 | chr12:75685286-75685287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs71078721 | chr12:75685303-75685304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs559414144 | chr12:75685318-75685319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs144431384 | chr12:75685320-75685321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs5799217 | chr12:75685332-75685333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs546855627 | chr12:75685371-75685372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs566846039 | chr12:75685373-75685374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Breast cancer | 17133270 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:75679600-75699200 | Weak transcription | Aorta | Aorta |
2 | chr12:75681200-75711400 | Weak transcription | Psoas Muscle | Psoas |
3 | chr12:75682200-75691800 | Weak transcription | Ovary | ovary |
4 | chr12:75682200-75699200 | Weak transcription | Right Ventricle | heart |
5 | chr12:75682600-75699200 | Weak transcription | Left Ventricle | heart |
6 | chr12:75683400-75697200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
7 | chr12:75684600-75685000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |